Regional tumor oxygen dynamics: 19F PBSR EPI of hexafluorobenzene

Magnetic Resonance Imaging

Volumn 15, Issue 8, 1997, Pages 971-981

  Le, Dennis ^a   Mason, Ralph P ^a,b   Hunjan, Sandeep ^a   Constantinescu, Anca ^a   Barker, Bruce R ^a   Antich, Peter P ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

19F magnetic resonance imaging; Echo planar imaging (EPI); Hexafluorobenzene; Oximetry; Tumor

Indexed keywords

HEXAFLUOROBENZENE; OXYGEN;

ACCURACY; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALIBRATION; DIAGNOSTIC VALUE; GENETIC HETEROGENEITY; HYPOXIA; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIMETRY; OXYGEN CONSUMPTION; OXYGEN TENSION; PRIORITY JOURNAL; RAT;

ADENOCARCINOMA; ANALYSIS OF VARIANCE; ANIMALS; CELL LINE; CHI-SQUARE DISTRIBUTION; DISEASE MODELS, ANIMAL; ECHO-PLANAR IMAGING; FLUOROCARBONS; MALE; OXIMETRY; OXYGEN; PROSTATIC NEOPLASMS; RATS;

ANIMALIA;

EID: 0030884025     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0730-725X(97)00035-0     Document Type: Article

References (50)

1. 1. Denekamp, J. Physiological hypoxia and its influence on radiotherapy. In: G.G. Steel, G.E. Adams, A. Horwich (Eds). The Biological Basis of Radiotherapy, 2nd Ed., Amsterdam: Elsevier, 1989: pp. 115-143.
2. 2. Chapman, J.D.; Stobbe, C.C.; Arnfield, M.R.; Santus, R.; Lee, J.; McPhee, M.S. Oxygen dependency of tumor cell killing in vitro by light activated photofrin II. Radiat. Res. 126:73-79; 1991.
3. 3. Brown, J.M.; Giaccia, A.J. Tumor hypoxia: The picture has changed in the 1990s. Int. J. Radiat. Biol. 65:95-102; 1994.
4. 4. Stratford, I.J.; Adams, G.E.; Bremmer, J.C.M.; Cole, S.; Edwards, H.S.; Robertson, N.; Wood, P.J. Manipulation and exploitation of the tumour environment for therapeutic benefit. Int. J. Radiat. Biol. 65:85-94; 1994.
5. 5. Stone, H.B.; Brown, J.M.; Phillips, T.; Sutherland, R.M. Oxygen in human tumors: Correlations between methods of measurement and response to therapy. Radiat. Res. 136:422-434; 1993.
6. 6. Sostman, H.D.; Rockwell, S.; Sylva, A.L.; Madwed, D.; Cofer, G.; Charles, H.C.; Negro-Villar, R.; Moore, D. Evaluation of BA 1112 rhabdomyosarcoma oxygenation with microelectrodes, optical spectrometry, radiosensitivity, and MRS. Magn. Reson. Med 20:253-267; 1991.
7. 2 in a murine fibrosarcoma. Radiat. Res. 120:477-493; 1989.
8. 8. Karczmar, G.S.; Kuperman, V.Y.; River, J.N.; Lewis, M.Z.; Lipton, M.J. Magnetic resonance measurement of response to hyperoxia differentiates tumors from normal tissue and may be sensitive to oxygen consumption. Invest. Radiol. 29:S161-163; 1994.
9. 9. Vexler, V.S.; de Crespigny, A.J.S.; Wendland, M.F.; Kuwatsuru, R.; Mühler, A.; Brasch, R.C.; Moseley, M.E. MR imaging of blood oxygenation-dependent changes in focal renal ischemia and transplanted liver tumor in rat. JMRI 3:483-490; 1993.
10. 19F NMR of perfluorocarbon. Art. Cells, Blood Sub., & Immob. Biotech. 22:1141-1153; 1994.
11. 11. Thomas, S.R. The biomedical applications of Fluorine-19 NMR. In: C.L. Partain, R.R. Price, J.A. Patton, M.V. Kulkarni, A.E.J. James (Eds). Magnetic Resonance Imaging. London: W.B. Saunders Co., 1988: pp. 1536-1552.
12. 12. Mason, R.P.; Antich, P.P.; Babcock, E.E.; Constantinescu, A.; Peschke, P.; Hahn, E.W. Non-invasive determination of tumor oxygen tension and local variation with growth. Int. J. Radiat. Oncol. Biol. Phys. 29:95-103; 1994.
13. 19F inversion-recovery echo-planar imaging of Perfluoro-15-crown-5-ether. Magn. Reson. Med. 32:88-97; 1994.
14. 31P magnetic resonance spectroscopy. Magn. Reson. Imaging 14:514-551; 1996.
15. 15. Fishman, J.E.; Joseph, P.M.; Carvlin, M.J.; Saadi-Elmandjra, M.; Mukherji, B.; Sloviter, H.S. In vivo measurements of vascular oxygen tension in tumors using MRI of a fluorinated blood substitute. Invest. Radiol. 24:65-71; 1989.
16. 19F MRI study in tumor-bearing mice. Magn. Reson. Imaging 7:475-485; 1989.
17. 17. Lutz, J.; Stark, M. Half life and changes in the composition of a perfluorochemical emulsion within the vascular system of rats. Pflugers Arch. 401:181-184; 1987.
18. 19F NMR indicator of tumor oxygenation. NMR in Biomed. 9:125-134; 1996.
19. 19F MRI and a new method for the suppression of chemical shift artifacts. J. Magn. Reson. B. 105:233-237; 1994.
20. 19F echo planar NMR imaging of sequestered perfluorocarbon. JMRI 4:595-602; 1994.
21. 1 with surface coils. J. Magn. Reson. 53:52-64; 1983.
22. 22. Barker, B.R.; Mason, R.P.; Peshock, R.M. Echo planar imaging of perfluorocarbons. Magn. Reson. Imaging 11: 1165-1173; 1993.
23. 19F NMR spectroscopy of perfluorocarbon. Magn. Reson. Med. 29:296-302; 1993.
24. 24. Bevington, P.R. In: Data Reduction and Error Analysis for the Physical Sciences. New York: MacGraw-Hill, 1969: pp. 72-73.
25. 25. Hahn, E.W.; Peschke, P.; Mason, R.P.; Babcock, E.E.; Antich, P.P. Isolated tumor growth in a surgically formed skin pedicle in the rat: A new tumor model for NMR studies. Magn. Reson. Imaging 11:1007-1017; 1993.
26. 26. Van Uijen, C.M.J.; Den Boef, J.H. Driven equilibrium radio-frequency pulses in NMR imaging. Magn. Reson. Med. 1:502-507; 1984.
27. 31P-MR spectroscopy and in-vivo radiosensitivity. In: P.W. Vaupel, D.K. Kelleher, M. Günderoth (Eds). Tumor Oxygenation. Stuttgart: Gustav Fischer, 1995: pp. 95-105.
28. 28. Yeh, K.A.; Biade, S.; Lanciano, R.M.; Brown, D.Q.; Fenning, M.C.; Babb, J.S.; Hanks, G.E.; Chapman, J.D. Polarographic needle electrode measurements of oxygen in rat prostate carcinomas: Accuracy and reproducibility. Int. J. Radiat. Oncol. Biol. Phys. 33:111-118; 1995.
29. 29. Terris, D.J.; Minchinton, A.I.; Dunphy, E.P.; Brown, J.M. Computerized histographic oxygen tension measurement of murine tumors. In: W. Erdmann, and D. F. Bruley, (Eds.). Oxygen Transport to Tissue XIV. New York: Plenum, 1992: pp. 153-159.
30. 30. Song, C.W.; Shakil, A.; Osborn, J.L.; Iwata, K. Tumour oxygenation is increased by hyperthermia at mild temperatures. Int. J. Hyperthermia 12:367-373; 1996.
31. 2 measurements in one rodent and two human xenografts. Radiat. Res. 139:1-8; 1994.
32. 2 tension measurements. Cancer Res. 51:3316-3322; 1991.
33. 33. Cater, D.; Silver, I. Quantitative measurements of oxygen tension in normal tissues and in the tumors of patients before and after radiotherapy. Acta Radiol. 53:233-256; 1960.
34. 19F NMR relaxometry of a perfluorocarbon emulsion. Magn. Reson. Med. 29:303-310; 1993 + erratum Magn. Reson. Med. 29:716 (1993).
35. 2 by perfluorochemicals and carbogen. Int. J. Radiat. Oncol. Biol. Phys. 13:569-574; 1987.
36. 2 histography. Br. J. Cancer 66:919-924; 1992.
37. 19F NMR probe at 4.7 T. Artif. Cells Blood Subst. Immob. Biotechnol. 22:1361-1367; 1994.
38. 38. Vaupel, P. Physiological properties of malignant tumors. NMR in Biomed. 5:220-225; 1992.
39. 39. Lartigau, E.; Lespinasse, F.; Vitu. L.; Guichard, M. Does the direct measurement of oxygen tension in tumors have adverse effects? Int. J. Radiat. Oncol. Biol. Phys. 22:949-951; 1992.
40. 2 imaging in the porcine model with perfluorocarbon F-19 NMR at low field. Magn. Reson. Imaging 14:103-114; 1996.
41. 19F NMR. Magn. Reson. Med. 29:446-458; 1993.
42. 19F MRI of sequestered perfluorocarbon. Magn. Reson. Med. 35:827-833; 1996.
43. 19F NMR spectroscopy of hexafluorobenzene. In: Book of ISMRM workshop on MR of Cancer Physiology and Metabolism; 85; 1996.
44. 44. Shukla, H.P.; Mason, R.P.; Woessner, D.E.; Antich, P.P. A comparison of three commercial perfluorocarbon emulsions as high field NMR probes of oxygen tension and temperature. J. Magn. Reson. Series B 106:131-14; 1995.
45. 45. Endo, K.; Yamamoto, K.; Kado, R. Fluorine-19 nuclear magnetic resonance relaxation analysis of the interaction of fluorocarbon with oxygen. Anal. Sci. 9:47-51; 1993.
46. 46. Mueller Klieser, W.; Vaupel, P. Spontaneous variations of blood supply and tissue temperature in peripheral subcutaneous tumors during anesthesia. In: R.F. Kallman, (Ed). Rodent Tumor Models in Experimental Cancer Therapy. New York: Pergamon, 1987: pp. 43-46.
47. 47. Mortelmanns, K.M. "In vitro" microbiological mutagenicity assays of eight fluorocarbon taggant samples. Gov. Rep. Announce Index (US) 81:2555; 1981.
48. 48. Courtney, K.D.; Andrews, J.E. Teratogenic evaluation and fetal deposition of hexabromobenzene (HBB) and hexafluorobenzene (HFB) in CD-1 mice. J. Environ. Sci. Health B 19:83-94; 1984.
49. 49. Grosman, Y.S.; Kapitonenko, T.A. Pharmacology and toxicology of hexafluorobenzene. Izv. Estestvennonauchu. Inst. Pevinsk. 15:155-63; 1973.
50. 50. Hall, L.W.; Jackson, S.R.K.; Massey, G.M. Hexafluorobenzene in veterinary anaesthesia. In: A. Arias, R. Llaurado, M.A. Nalda, J.N. Lunn (Eds). Recent Progress in Anaesthesiology and Resuscitation. Oxford: Excerpta Medica, 1975: pp. 201-204.